Pamela Blair Allen, MD, MSc

• A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

  • Phase

    III
  • Conditions

    Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
  • Location

    Winship Cancer Institute

• Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol

  • Phase

    Expanded Access
  • Conditions

    Lymphoma, Large B-Cell, Diffuse
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• • Phase

    N/A
  • Location

    Winship Cancer Institute

Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy.

Blood advances

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.

The Lancet. Oncology

Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.

Blood advances

Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.

CNS oncology

Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study.

Clinical lymphoma, myeloma & leukemia

DMF in CTCL: where do we go from here?

Blood

Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.

Blood advances

Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.

Blood advances

Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.

JAMA oncology

Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia.

Leukemia & lymphoma

Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.

Cancer

Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.

Cancer research communications

Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.

Clinical lymphoma, myeloma & leukemia

Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary Syndrome.

JAMA dermatology

CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.

Clinical lymphoma, myeloma & leukemia

African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center.

Leukemia & lymphoma

Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.

Clinical lymphoma, myeloma & leukemia

Racial differences in clinical presentation and outcomes in mycosis fungoides and Sézary syndrome in the United States: a large singe center retrospective analysis.

European journal of cancer (Oxford, England : 1990)

T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma.

JAMA dermatology

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.

Blood

Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer.

Oncology (Williston Park, N.Y.)

Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy.

Clinical lymphoma, myeloma & leukemia

Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL).

Leukemia & lymphoma

Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Blood

Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.

Current oncology reports

A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma.

Leukemia & lymphoma

Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia.

Cancer

08/05/2024

They talk fast and over your head. I only made through the the 11th grade. So you need to talk to me like i'm a teenager not a professor

01/04/2024

Dr. Allen provided excellent care & instruction and was able to get me BACK in the infusion skd.

19/01/2024

Loved Dr. Allen. Very knowledgeable and spent lots of time with us and answered all our questions that she could without further testing

13/09/2023

It was a thorough visit.

23/08/2023

Thank you Dr. Allen and Winship cancer center.

26/07/2023

My Doctor gives you her undivided attention and show complete concern when I ask questions.

03/06/2023

Dr Pamela Allen has been very clear and easy to talk with.

10/05/2023

Excellent!

24/02/2023

Dr Allen exuded a reassuring air of professionalism, compassion, and concern for my wellbeing. I left the appointment with all of my questions answered, and I feel very reassured that my treatment is in good hands with Dr Allen's team at Emory.

15/01/2023

I love doctor Allen. She is very caring and professional. Makes sure we understand what she is explaining to us. I chose to have her as my doctor instead of the first one I have. I live in Grovetown Georgia and we travel there if we have to. I agree with everyone that tells me Emory is the best and helped them.

11/01/2023

My visit with Dr. Allen was excellent...it's just that the news was not what I had hoped for.

08/01/2023

Very pleased with Dr. Allen

11/11/2022

Amazing Dr... Very thorough

21/09/2022

Good experince

11/06/2022

Everything went well.

28/05/2022

Overall EXCELLENT